Dr. Pisarcik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8405 N Pima Center Pkwy
Ste 201
Scottsdale, AZ 85258Phone+1 480-587-6775
Education & Training
Ohio State University HospitalFellowship, Rheumatology, 2022 - 2024
Indiana University School of MedicineResidency, Internal Medicine, 2019 - 2022
Philadelphia College of Osteopathic MedicineClass of 2019
Certifications & Licensure
OH State License 2022 - 2026
AZ State License 2024 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 1 citationsDirect-acting antiviral agents decrease haemoglobin A1c level in patients with diabetes infected with hepatitis C virus: A systematic review & meta-analysis.Kamolyut Lapumnuaypol, David Pisarcik, Prapaipan Putthapiban, Weera Sukhumthammarat, Karn Wijarnpreecha
The Indian Journal of Medical Research. 2020-06-01 - 23 citationsEffects of inflammatory bowel disease treatment on the risk of nonalcoholic fatty liver disease: a meta-analysis.Kamolyut Lapumnuaypol, Napatt Kanjanahattakij, David Pisarcik, Charat Thongprayoon, Karn Wijarnpreecha
European Journal of Gastroenterology & Hepatology. 2018-08-01 - 3 citationsThe Evolution of Clinical Trials in Renal Cell Carcinoma: A Status Report for 2013-2016 from the ClinicalTrials.gov Website.Pooja Ghatalia, Rebecca Koenigsberg, David Pisarcik, Elizabeth Handorf, Daniel M. Geynisman
Kidney Cancer. 2017-11-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
